U.S.-U.K. Negotiations Could Lead To Higher Drug Spending In Britain

The U.K.'s National Institute for Health and Care Excellence may raise the cost-effectiveness threshold for the first time in 26 years. This threshold represents the maximum amount that a healthcare system is willing to pay for an additional unit of health benefit, typically measured in terms of quality-adjusted life years. It is not a rigid cutoff, though. Rather, it serves as a signal as to what the government is willing to pay. Getty

There’s been a sharp decline in foreign direct investment in the British life sciences sector in recent years, as it fell by 58% from £1.9 ($2.5) billion in 2021 to £795 million ($1.04 billion) in 2023. According to FirstWord Pharma , to “stem the outflow of investment and to appease President Trump” the British government is considering raising th